戻る Agenda
LS03 Realization of Personalized Medicine through Reverse Translational Research
Session Chair(s)
Yuichi Kubo, MSC
Corporate Advisor, Daiichi Sankyo Co., Ltd., Japan
Speaker(s)
Masayuki Yamamoto, MD, PHD
Executive Director, Professor, Tohoku University graduate School of Medicine, Tohoku Medical Megabank organization, Japan
Takao Shimizu, MD
Project Manager, Department of Lipid Signaling, National Center for Global Health and Medicine, Japan
Masato Murakami, MD, PHD, MBA
VP, Global Chair of Precision Medicine, R&D Division, Daiichi Sankyo, Co., Ltd., Japan
Akira Kitamura
General Manager, AI Drug Development Division, NEC Corporation, Japan